News and Press Releases

Prosarix collaborates with Dr Reddy's Laboratories

Cambridge, UK, January 7th 2008 — Prosarix has entered into a collaboration with Dr Reddy's Laboratories in which Prosarix will utilize its computational platform (ProtoDiscovery™) in one of Dr Reddy's early stage R&D programs. Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The Company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The Company conducts research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection.


©Prosarix 2007-2020

℅ RxCelerate Ltd, Moneta B280, Babraham Research Park, Cambridge, CB22 3AT ¦ +44 (0)1223 839557 ¦ ¦ legal